Abstract
Purpose
The purpose of this study was to compare the prognosis of oral tongue cancer patients and base of tongue cancer patients.
Methods
One hundred oral tongue cancer patients (group A) were matched with 50 base of tongue cancer patients (group B) for gender, age, T-stage, and tumor differentiation in this study. Survival rate was performed using the Kaplan–Meier analysis, and multivariate analysis was conducted using the Logistic regression model.
Results
There was difference in the survival rate between the two groups. Three- and 5-year OS (overall survival) of the two groups were 65.0, 51.0% for group A and 40.0, 28.0% for group B, respectively. For the two groups, 3- and 5-year DSS (disease-specific survival) were 61.0, 46.0% for group A and 38.0, 26.0% for group B, respectively. Multivariate analysis showed that recurrence (P = 0.019) and regional lymph node metastasis (P = 0.043) were significant between the group A and group B patients.
Conclusion
The oral tongue cancer patients had a better prognosis than base of tongue cancer patients. The difference in prognosis between the oral tongue cancer and the base of tongue cancer patients in this study was closely associated with the recurrence and regional lymph node metastasis. We conclude that the individual treatment should be used for base of tongue cancer patients.
Similar content being viewed by others
References
Attner P, Du J, Nasman A et al (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879–2884
Birnbaum A, Dipetrillo T, Rathore R et al (2010) Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis. Am J Clin Oncol 33:144–147
Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21–28
Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P (2004) Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:546–552
Hammarstedt L, Lu Y, Marklund L, Dalianis T, Munck-Wikland E, Ye W (2011) Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol 47:636–641
Harrison LB, Lee HJ, Pfister DG et al (1998) Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 20:668–673
Ho HC, Lee MS, Hsiao SH et al (2008) Squamous cell carcinoma of the oral cavity in young patients: a matched-pair analysis. Eur Arch Otorhinolaryngol 265(Suppl 1):S57–S61
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Kies MS, Holsinger FC, Lee JJ et al (2010) Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol 28:8–14
Kraus DH, Vastola AP, Huvos AG, Spiro RH (1993) Surgical management of squamous cell carcinoma of the base of the tongue. Am J Surg 166:384–388
Lam L, Logan RM, Luke C (2006) Epidemiological analysis of tongue cancer in South Australia for the 24-year period, 1977–2001. Aust Dent J 51:16–22
Lam L, Logan RM, Luke C, Rees GL (2007) Retrospective study of survival and treatment pattern in a cohort of patients with oral and oropharyngeal tongue cancers from 1987 to 2004. Oral Oncol 43:150–158
Lill C, Kornek G, Bachtiary B et al (2011) Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr 123:215–221
Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Moore-Higgs GJ, Cassisi NJ (2000) Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol 18:35–42
Merlano M, Russi E, Benasso M et al (2011) Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Ann Oncol 22:712–717
Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of tongue cancer: a review of global incidence. Oral Dis 6:75–84
Park JO, Sun DI, Cho KJ, Joo YH, Yoo HJ, Kim MS (2010) Clinical outcome of squamous cell carcinoma of the tongue in young patients: a stage-matched comparative analysis. Clin Exp Otorhinolaryngol 3:161–165
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Petersen PE (2009) Oral cancer prevention and control–the approach of the World Health Organization. Oral Oncol 45:454–460
Reddy VM, Cundall-Curry D, Bridger MW (2010) Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006. Ann R Coll Surg Engl 92:655–659
Rusthoven K, Ballonoff A, Raben D, Chen C (2008) Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 112:345–351
Selzer E, Liederer S, Lemaire C et al (2011) Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab. Strahlenther Onkol 187:373–377
Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA (2003) Analysis of treatment results for base of tongue cancer. Laryngoscope 113:1252–1261
Shim SJ, Cha J, Koom WS et al (2010) Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol 5:43
Suntharalingam M, Kwok Y, Goloubeva O et al (2011) Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and Neck. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2011.02.062
Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR (2004) The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 26:660–674
Acknowledgments
The authors thank Jon Teng for help with modifying the paper.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, L., Zhou, X., Yao, X. et al. Oral tongue cancer patients show a better overall survival than base of tongue cancer patients. J Cancer Res Clin Oncol 138, 341–346 (2012). https://doi.org/10.1007/s00432-011-1105-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-011-1105-y